BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 270015)

  • 1. Chemotherapy of bladder cancer: current progress.
    Murphy GP
    N Y State J Med; 1977 Oct; 77(12):1889-95. PubMed ID: 270015
    [No Abstract]   [Full Text] [Related]  

  • 2. Intracavitary treatment of transitional cell carcinoma of the bladder: questions and lessons after 27 years of experience.
    Kurth KH; Sylvester R; de Pauw M; ten Kate F
    Prog Clin Biol Res; 1989; 310():125-45. PubMed ID: 2672012
    [No Abstract]   [Full Text] [Related]  

  • 3. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base.
    David KA; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
    J Urol; 2007 Aug; 178(2):451-4. PubMed ID: 17561135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of systemic chemotherapy in the treatment of infiltrating cancer of the bladder].
    Gardella S; Estapé J
    Med Clin (Barc); 1989 Dec; 93(18):693-5. PubMed ID: 2607820
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of hematoporphyrin derivative (HpD) in the localization and treatment of transitional cell carcinoma (TCC) of the bladder.
    Benson RC
    Prog Clin Biol Res; 1984; 170():795-804. PubMed ID: 6241716
    [No Abstract]   [Full Text] [Related]  

  • 6. [Low-grade, low-stage transitional carcinoma of the bladder. Analysis of 147 cases].
    Escudero Barrilero A; Gutiérrez Sanz-Gadea C; Hernández Fernández C; Mateos Torres A; Maganto Pavón E; Mayayo Dehesa T
    Actas Urol Esp; 1985; 9(2):135-46. PubMed ID: 3925729
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of azauridine in cancer of the urinary bladder].
    Erukhimov LS; Vermel' EM
    Vopr Onkol; 1969; 15(5):91. PubMed ID: 5360151
    [No Abstract]   [Full Text] [Related]  

  • 8. [Intravesical chemotherapy of bladder cancer using adriamycin].
    Matveev BP; Shipilov VI; Romanov VA; Minakova LR; Gorilovskiĭ LM
    Urol Nefrol (Mosk); 1984; (5):6-9. PubMed ID: 6506387
    [No Abstract]   [Full Text] [Related]  

  • 9. Photodynamic therapy Tis and T1 transitional carcinoma of the bladder.
    Javadpour N
    Prog Clin Biol Res; 1989; 303():471-8. PubMed ID: 2780658
    [No Abstract]   [Full Text] [Related]  

  • 10. [Photodynamic therapy for genitourinary carcinomas--report of 26 tumors in 17 patients].
    Huang JG
    Zhonghua Zhong Liu Za Zhi; 1991 Jan; 13(1):55-7. PubMed ID: 1832375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of superficial carcinoma of the bladder.
    Paulson DF
    Prog Clin Biol Res; 1984; 162B():193-209. PubMed ID: 6209720
    [No Abstract]   [Full Text] [Related]  

  • 12. [Arterial infusion chemotherapy for patients with advanced and moderately advanced cancer of urinary bladder].
    Li Q; Xu X; Liu J
    Zhonghua Zhong Liu Za Zhi; 1998 Jul; 20(4):308-9. PubMed ID: 10920993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemotherapy for advanced urothelial cancer patients with a combination of low-dose consecutive cisplatin and etoposide].
    Hashimoto H; Tokumitsu M; Morikawa M; Numata A; Yachiku S; Iuchi H; Yamauchi K
    Gan To Kagaku Ryoho; 1996 Jun; 23(7):941-4. PubMed ID: 8678548
    [No Abstract]   [Full Text] [Related]  

  • 14. [Intracavitary treatment of tumors of the bladder with cytotoxic agent (mitomycin C) and radioactive phosphorus (32P). 3].
    Ogawa H
    Nihon Hinyokika Gakkai Zasshi; 1969 Aug; 60(8):728-45. PubMed ID: 5388928
    [No Abstract]   [Full Text] [Related]  

  • 15. A phase II study of carboplatin in metastatic transitional cell carcinoma of the bladder (a report of the Medical Research Council Working Party on Urological Cancer, Subgroup in Advanced Bladder Cancer).
    Eur J Cancer Clin Oncol; 1987 Apr; 23(4):375-7. PubMed ID: 3301367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant chemotherapy of bladder cancer.
    Freiha FS; Torti FM
    Prog Clin Biol Res; 1988; 260():545-9. PubMed ID: 3129738
    [No Abstract]   [Full Text] [Related]  

  • 17. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
    Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy of bladder cancer: current status and prospects.
    Smith WK; Koontz WW
    Va Med; 1979 Feb; 106(2):131-4. PubMed ID: 425674
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cyclooxygenase-2-expression in bladder cancer: tumor-biological and clinical implications].
    Wülfing C; Eltze E; Von Struensee D; Wülfing P; Bode ME; Bettendorf O; Piechota H; Hertle L
    Aktuelle Urol; 2004 Aug; 35(4):331-8. PubMed ID: 15459875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recurrence rate in adjuvant local chemotherapy of bladder cancer with mitomycin C].
    Flüchter SH; Harzmann R; Erdmann D; Bichler KH
    Helv Chir Acta; 1982 Aug; 49(3-4):349-52. PubMed ID: 6813293
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.